share_log

我武生物(300357.SZ):干细胞治疗药物目前处在临床前研究阶段

Obu Biology (300357.SZ): Stem cell therapy is currently in the preclinical research stage

Gelonghui Finance ·  Jan 24 08:43

Gelonghui January 24 丨 Our Wu Biology (300357.SZ) was surveyed by a specific target on January 24, 2024, about “How is the development progress of the company's stem cell products?” The company replied that the company's stem cell therapy is currently in the preclinical research stage and has not submitted an application for clinical trials.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment